Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pain 20Neoplasms 19Cancer Pain 16Pain, Postoperative 12Agnosia 8Chronic Pain 7Breast Neoplasms 5Neoplasm Metastasis 4Head and Neck Neoplasms 4Colorectal Neoplasms 4Colonic Neoplasms 4Multiple Myeloma 3Mucositis 3Lymphoma, Follicular 3Lymphoma 3Lung Neoplasms 3Leukemia, Myeloid, Acute 3Leukemia, Biphenotypic, Acute 3Leukemia 3Wounds and Injuries 2Waldenstrom Macroglobulinemia 2Thrombocythemia, Essential 2Supratentorial Neoplasms 2Sezary Syndrome 2Primary Myelofibrosis 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Precancerous Conditions 2Polycythemia Vera 2Pdgfra-Associated Chronic Eosinophilic Leukemia 2

Interventions

Morphine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Skin Ulcer × Morphine × Clear all
NCT00306020 2012-07-04

Analgesia and Wound Healing Assessment Following Topical Morphine Applied to Patients With Cutaneous Cancer Related Pain

Soroka University Medical Center

Phase NA Withdrawn

Neoplasms, Skin Ulcer, Ulcer, Wounds and Injuries, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡